Acute kidney injury in patients hospitalized with COVID-19 JS Hirsch, JH Ng, DW Ross, P Sharma, HH Shah, RL Barnett, AD Hazzan, ... Kidney international 98 (1), 209-218, 2020 | 1717 | 2020 |
COVID-19–associated kidney injury: a case series of kidney biopsy findings P Sharma, NN Uppal, R Wanchoo, HH Shah, Y Yang, R Parikh, Y Khanin, ... Journal of the American Society of Nephrology 31 (9), 1948-1958, 2020 | 410 | 2020 |
Adverse renal effects of immune checkpoint inhibitors: a narrative review R Wanchoo, S Karam, NN Uppal, VS Barta, G Deray, C Devoe, ... American journal of nephrology 45 (2), 160-169, 2017 | 325 | 2017 |
Outcomes among patients hospitalized with COVID-19 and acute kidney injury JH Ng, JS Hirsch, A Hazzan, R Wanchoo, HH Shah, DA Malieckal, ... American Journal of Kidney Diseases 77 (2), 204-215. e1, 2021 | 314 | 2021 |
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19 JH Ng, JS Hirsch, R Wanchoo, M Sachdeva, V Sakhiya, S Hong, ... Kidney international 98 (6), 1530-1539, 2020 | 297 | 2020 |
Thrombotic microangiopathy in a patient with COVID-19 KD Jhaveri, LR Meir, BSF Chang, R Parikh, R Wanchoo, ... Kidney international 98 (2), 509-512, 2020 | 171 | 2020 |
The evolution of the journal club: from Osler to Twitter JM Topf, MA Sparks, PJ Phelan, N Shah, EV Lerma, MPM Graham-Brown, ... American Journal of Kidney Diseases 69 (6), 827-836, 2017 | 165 | 2017 |
Pathophysiology and pathology of acute kidney injury in patients with COVID-19 JH Ng, V Bijol, MA Sparks, ME Sise, H Izzedine, KD Jhaveri Advances in Chronic Kidney Disease 27 (5), 365-376, 2020 | 162 | 2020 |
De novo ANCA-associated vasculitis with glomerulonephritis in COVID-19 NN Uppal, N Kello, HH Shah, Y Khanin, IR De Oleo, E Epstein, P Sharma, ... Kidney international reports 5 (11), 2079-2083, 2020 | 159 | 2020 |
Glomerular diseases seen with cancer and chemotherapy: a narrative review KD Jhaveri, HH Shah, K Calderon, ES Campenot, J Radhakrishnan Kidney international 84 (1), 34-44, 2013 | 145 | 2013 |
Acute kidney injury in patients treated with immune checkpoint inhibitors S Gupta, SAP Short, ME Sise, JM Prosek, SM Madhavan, MJ Soler, ... Journal for immunotherapy of cancer 9 (10), 2021 | 140 | 2021 |
Preserved renal-allograft function and the PD-1 pathway inhibitor nivolumab R Barnett, VS Barta, KD Jhaveri New England Journal of Medicine 376 (2), 191-192, 2017 | 138 | 2017 |
Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network B Sprangers, V Nair, V Launay-Vacher, LV Riella, KD Jhaveri Clinical Kidney Journal 11 (3), 315-329, 2018 | 135 | 2018 |
Why not nephrology? A survey of US internal medicine subspecialty fellows KD Jhaveri, MA Sparks, HH Shah, S Khan, A Chawla, T Desai, E Iglesia, ... American Journal of Kidney Diseases 61 (4), 540-546, 2013 | 126 | 2013 |
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant N Murakami, P Mulvaney, M Danesh, A Abudayyeh, A Diab, ... Kidney international 100 (1), 196-205, 2021 | 121 | 2021 |
The social media revolution in nephrology education GB Colbert, J Topf, KD Jhaveri, T Oates, MN Rheault, S Shah, S Hiremath, ... Kidney international reports 3 (3), 519-529, 2018 | 121 | 2018 |
Onconephrology: the intersections between the kidney and cancer MH Rosner, KD Jhaveri, BA McMahon, MA Perazella CA: a cancer journal for clinicians 71 (1), 47-77, 2021 | 120 | 2021 |
A systematic review of immune checkpoint inhibitor–associated glomerular disease A Kitchlu, KD Jhaveri, S Wadhwani, P Deshpande, Z Harel, T Kishibe, ... Kidney international reports 6 (1), 66-77, 2021 | 106 | 2021 |
Update on membranoproliferative GN N Masani, KD Jhaveri, S Fishbane Clinical Journal of the American Society of Nephrology 9 (3), 600-608, 2014 | 92 | 2014 |
Adverse renal effects of novel molecular oncologic targeted therapies: a narrative review KD Jhaveri, R Wanchoo, V Sakhiya, DW Ross, S Fishbane Kidney International Reports 2 (1), 108-123, 2017 | 86 | 2017 |